F13.98 Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders

Name of the Condition

• Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders

Summary

This condition refers to the use of sedative, hypnotic, or anxiolytic substances where the pattern of use is not specified, and there is co-occurring sedative, hypnotic, or anxiolytic-induced disorder(s). These drugs are commonly prescribed for anxiety, insomnia, or sedation but may be used in ways that do not meet criteria for a more specific disorder. The unspecified nature indicates insufficient detail to classify the pattern of use further, while the induced disorder(s) represent complications from substance use.

Causes

The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. Use may be prescribed or non-medical, and the unspecified nature indicates insufficient detail to classify the pattern of use beyond the presence of induced disorder(s). Induced disorders may include conditions like withdrawal, intoxication, or other substance-related complications.

Risk Factors

• Prolonged or excessive use of these medications
• History of substance use disorders
• Underlying mental health conditions (e.g., anxiety, depression)
• Easy access to sedative/hypnotic/anxiolytic drugs
• Recreational or non-medical use

Symptoms

• Variable depending on the context of use and the specific induced disorder(s)
• May include cravings, tolerance, or withdrawal symptoms if use is prolonged
• Symptoms of the co-occurring induced disorder(s) (e.g., sedation, confusion, or withdrawal signs)
• No specific symptoms are required for the unspecified use component

Diagnosis

Diagnosis is based on clinical evaluation of substance use history and assessment of the pattern of use. The unspecified nature indicates that criteria for a more specific disorder (e.g., abuse, dependence) are not met or documented, while the presence of induced disorder(s) is confirmed through clinical assessment or laboratory testing. Documentation should specify the type of induced disorder(s) present.

Treatment Options

Treatment focuses on managing the induced disorder(s) and addressing the underlying substance use. Options may include:

• Monitoring for potential misuse or dependence
• Education on safe medication use
• Symptomatic treatment for induced disorder(s) (e.g., withdrawal management)
• Referral to substance use disorder specialists if needed

Prognosis and Follow-Up

Prognosis depends on the severity of the induced disorder(s) and the pattern of substance use. Regular follow-up is recommended to monitor for complications, adjust treatment, and assess for progression to more specific substance use disorders. Early intervention improves outcomes.

Complications

• Worsening of induced disorder(s) (e.g., severe withdrawal, prolonged intoxication)
• Development of dependence or abuse
• Increased risk of overdose or adverse drug interactions
• Impact on mental or physical health (e.g., cognitive impairment, respiratory depression)

Lifestyle & Prevention

• Use medications only as prescribed and avoid non-medical use
• Avoid mixing sedative, hypnotic, or anxiolytic drugs with alcohol or other substances
• Seek alternative therapies for anxiety or insomnia (e.g., cognitive behavioral therapy)
• Maintain open communication with healthcare providers about substance use

When to Seek Professional Help

Seek immediate medical attention if experiencing severe symptoms of intoxication (e.g., difficulty breathing, loss of consciousness) or withdrawal (e.g., seizures, severe agitation). Consult a healthcare provider for ongoing substance use concerns or if induced disorder(s) persist.

Tips for Medical Coders

Document the presence of sedative, hypnotic, or anxiolytic-induced disorder(s) to support the F13.98 code. Ensure clinical notes specify the type of induced disorder(s) (e.g., withdrawal, intoxication) and confirm the unspecified nature of the substance use pattern. Avoid using this code if a more specific pattern of use (e.g., dependence, abuse) is documented.